|
Recruiting and enrolling minority patients to cancer clinical trials
1 Massachusetts General Hospital/Harvard Medical School, Boston, MA, and 2 Memorial Sloan-Kettering Cancer Center, New York, NY
In an effort to improve minority participation in clinical trials, the United States government passed the National Institutes of Health Revitalization Act of 1993, which mandated the inclusion of women and minorities in clinical research. The National Cancer Institute launched the Minority-Based Community Clinical Oncology Program to increase access to cancer clinical trials among racial and ethnic minorities. Although these initiatives have resulted in some success, minority participation in cancer clinical trials remains low. This article reviews the problem and the reasons why it is important, and offers a number of specific solutions.
| Commun Oncol 2007;4:254–257 | full text |  126 kb |